Hypohidrotic ectodermal dysplasia is one of more than 100 types of ectodermal dysplasia. Starting before birth, these disorders result in the abnormal development of ectodermal tissues, particularly the skin, hair, nails, teeth, and sweat glands.
Hypohidrotic ectodermal dysplasia is a genetic condition that can result from mutations in one of several genes. These include EDA, EDAR, EDARADD, and WNT10A. EDA gene mutations are the most common cause of the disorder, accounting for more than half of all cases. EDAR, EDARADD, and WNT10A gene mutations each account for a smaller percentage of cases. In about 10 percent of people with hypohidrotic ectodermal dysplasia, the genetic cause is unknown.
Hypohidrotic ectodermal dysplasia is the most common form of ectodermal dysplasia. It is estimated to occur in 1 in 20,000 newborns worldwide.
Hypohidrotic ectodermal dysplasia has several different inheritance patterns. Most cases are inherited in an X-linked pattern and are caused by mutations in the EDA gene. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females, who have two copies of the X chromosome, one altered copy of the gene in each cell often leads to less severe features of the condition. Signs and symptoms can include a few missing or abnormal teeth, sparse hair, and mild problems with sweat gland function. However, some females with one copy of the mutated gene have more severe features of this disorder.
Holm Schneider practices in Erlangen, Germany. Schneider is rated as an Elite expert by MediFind in the treatment of Hypohidrotic Ectodermal Dysplasia. They are also highly rated in 10 other conditions, according to our data. Their top areas of expertise are Hypohidrotic Ectodermal Dysplasia, Aplasia Cutis Congenita, Ectodermal Dysplasias, Clouston Syndrome, and Hormone Replacement Therapy (HRT).
Michele Callea practices in Rome, Italy. Callea is rated as an Elite expert by MediFind in the treatment of Hypohidrotic Ectodermal Dysplasia. They are also highly rated in 8 other conditions, according to our data. Their top areas of expertise are Hypohidrotic Ectodermal Dysplasia, Ectodermal Dysplasias, Clouston Syndrome, and Aplasia Cutis Congenita.
Sigrun Wohlfart practices in Erlangen, Germany. Wohlfart is rated as an Elite expert by MediFind in the treatment of Hypohidrotic Ectodermal Dysplasia. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Hypohidrotic Ectodermal Dysplasia, Clouston Syndrome, Ectodermal Dysplasias, and Aplasia Cutis Congenita.
Summary: This is an open-label, prospective, genotype-match controlled for primary estimand, non randomized, multicenter, international Phase 2 clinical trial designed to investigate the efficacy and safety of ER004 administered intraamniotically as a treatment for unborn XLHED male subjects.
Summary: The aim of the study is to compare sleep efficiency by means of actigraphy in patients with hypohidrotic ectodermal dysplasia with healthy controls. Sleep efficiency, assessed on actigraphy, sleep architecture assessed on on polysomnography, body temperature and urine melatonin levels will be compared between the patients with hypohidrotic ectodermal dysplasia with healthy controls.
Published Date: November 01, 2018Published By: National Institutes of Health